International Flavors & Fragrances Inc. IFF
87.67 USD -4.51 (-4.89%)
At closeNov 4, 2026, 4:39 PM EST
87.67 0.00 0.00%
After hours · Nov 4, 4:39 PM ET
84.16 Day range 89.96
61.73 52-week range 95.27
- YTD
- +30.09%
- 1 year
- +42.58%
Analyst view
Consensus: buy
Buy
Price target (mean) 97.47 +11.2% upside
Now 87.67
- Target (low)
- 76.00
- Target (mean)
- 97.47
- Target (high)
- 110.00
Ratings (0m) 20 14 buy · 6 hold · 0 sell
- Strong buy4
- Buy10
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 20
- 1 month ago 20
- 2 months ago 20
- 3 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.63 | 0.63 – 0.63 | 0.80 | -21.3% | 1.81B | -30.1% | 1 |
| Next quarter | 0.936 | 0.91 – 1.00 | 1.25 | -25.1% | 1.97B | -28.3% | 4 |
| Current year | 3.15 | 3.15 – 3.15 | 4.20 | -25.0% | 7.53B | -30.9% | 1 |
| Next year | 3.93 | 3.40 – 4.69 | 3.15 | +24.6% | 7.84B | +4.1% | 18 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 22, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 16, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 7, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 7, 2026 | Argus Research | Maintained | Buy | Buy |
| Sep 11, 2026 | Keybanc | Initiated | — | Sector Weight |
| Aug 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 6, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 6, 2026 | Benchmark | Maintained | Buy | Buy |
| Jul 1, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 30, 2026 | Argus Research | Maintained | Buy | Buy |
| Jun 24, 2026 | Citigroup | Maintained | Buy | Buy |
| Jun 9, 2026 | Benchmark | Initiated | — | Buy |
| May 8, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 7, 2026 | Citigroup | Maintained | Buy | Buy |
| May 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 7, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 22, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 13, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 9, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 17, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 17, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Feb 13, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 13, 2026 | Oppenheimer | Upgrade | Perform | Outperform |
| Feb 13, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 12, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jan 22, 2026 | Argus Research | Maintained | Buy | Buy |
| Jan 21, 2026 | Citigroup | Maintained | Buy | Buy |
| Jan 12, 2026 | UBS | Maintained | Neutral | Neutral |
| Nov 7, 2025 | Barclays | Maintained | Overweight | Overweight |
